False-positive results in urine drug screening in healthy volunteers participating in phase 1 studies with efavirenz and rifampin

Radboud University Nijmegen, Nymegen, Gelderland, Netherlands
Therapeutic Drug Monitoring (Impact Factor: 2.38). 05/2006; 28(2):286. DOI: 10.1097/01.ftd.0000199359.87636.5d
Source: PubMed
Download full-text


Available from: David Burger, Jan 20, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Drug testing, commonly used in health care, workplace, and criminal settings, has become widespread during the past decade. Urine drug screens have been the most common method for analysis because of ease of sampling. The simplicity of use and access to rapid results have increased demand for and use of immunoassays; however, these assays are not perfect. False-positive results of immunoassays can lead to serious medical or social consequences if results are not confirmed by secondary analysis, such as gas chromatography-mass spectrometry. The Department of Health and Human Services' guidelines for the workplace require testing for the following 5 substances: amphetamines, cannabinoids, cocaine, opiates, and phencyclidine. This article discusses potential false-positive results and false-negative results that occur with immunoassays of these substances and with alcohol, benzodiazepines, and tricyclic antidepressants. Other pitfalls, such as adulteration, substitution, and dilution of urine samples, are discussed. Pragmatic concepts summarized in this article should minimize the potential risks of misinterpreting urine drug screens.
    Mayo Clinic Proceedings 02/2008; 83(1):66-76. DOI:10.4065/83.1.66 · 6.26 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We investigated the effect of efavirenz treatment on the results of drug screening tests of urine samples obtained from 100 patients infected with human immunodeficiency virus. Of 50 patients who received efavirenz, 49 tested positive for benzodiazepines in ≥1 drug screening test, whereas of 50 patients who did not receive efavirenz, only 1 tested positive for benzodiazepines in ≥ drug screening test. The major metabolite 8-hydroxy-efavirenz is responsible for this cross- reactivity. © 2009 by the Infectious Diseases Society of America. All rights reserved.
    Clinical Infectious Diseases 06/2009; 48(12):1787-9. DOI:10.1086/599109 · 8.89 Impact Factor
  • Source

    Anales de Pediatría Continuada 05/2010; 8(3):139-143. DOI:10.1016/S1696-2818(10)70025-1
Show more